Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: A4H750
Term | Name | Level | Count |
---|---|---|---|
GO:0006040 | amino sugar metabolic process | 4 | 7 |
GO:0006047 | UDP-N-acetylglucosamine metabolic process | 4 | 7 |
GO:0006048 | UDP-N-acetylglucosamine biosynthetic process | 5 | 7 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 7 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 7 |
GO:0006793 | phosphorus metabolic process | 3 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009058 | biosynthetic process | 2 | 7 |
GO:0009225 | nucleotide-sugar metabolic process | 4 | 7 |
GO:0009226 | nucleotide-sugar biosynthetic process | 5 | 7 |
GO:0009987 | cellular process | 1 | 7 |
GO:0018130 | heterocycle biosynthetic process | 4 | 7 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 7 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 7 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 7 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0044249 | cellular biosynthetic process | 3 | 7 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 7 |
GO:0044281 | small molecule metabolic process | 2 | 7 |
GO:0046349 | amino sugar biosynthetic process | 5 | 7 |
GO:0046483 | heterocycle metabolic process | 3 | 7 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 7 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4 | 7 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 7 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 7 |
GO:1901576 | organic substance biosynthetic process | 3 | 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 7 |
GO:0004343 | glucosamine 6-phosphate N-acetyltransferase activity | 7 | 7 |
GO:0008080 | N-acetyltransferase activity | 6 | 7 |
GO:0016407 | acetyltransferase activity | 5 | 7 |
GO:0016410 | N-acyltransferase activity | 5 | 7 |
GO:0016740 | transferase activity | 2 | 7 |
GO:0016746 | acyltransferase activity | 3 | 7 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 18 | 22 | PF00656 | 0.390 |
CLV_C14_Caspase3-7 | 26 | 30 | PF00656 | 0.305 |
CLV_NRD_NRD_1 | 180 | 182 | PF00675 | 0.420 |
CLV_PCSK_FUR_1 | 178 | 182 | PF00082 | 0.362 |
CLV_PCSK_KEX2_1 | 180 | 182 | PF00082 | 0.420 |
CLV_PCSK_KEX2_1 | 42 | 44 | PF00082 | 0.336 |
CLV_PCSK_PC1ET2_1 | 42 | 44 | PF00082 | 0.336 |
CLV_PCSK_SKI1_1 | 116 | 120 | PF00082 | 0.427 |
CLV_PCSK_SKI1_1 | 225 | 229 | PF00082 | 0.342 |
CLV_PCSK_SKI1_1 | 231 | 235 | PF00082 | 0.284 |
CLV_PCSK_SKI1_1 | 42 | 46 | PF00082 | 0.450 |
CLV_PCSK_SKI1_1 | 59 | 63 | PF00082 | 0.404 |
DEG_MDM2_SWIB_1 | 228 | 235 | PF02201 | 0.231 |
DOC_CYCLIN_yCln2_LP_2 | 261 | 267 | PF00134 | 0.255 |
DOC_MAPK_MEF2A_6 | 151 | 159 | PF00069 | 0.636 |
DOC_PP2B_LxvP_1 | 261 | 264 | PF13499 | 0.315 |
DOC_USP7_MATH_1 | 146 | 150 | PF00917 | 0.536 |
DOC_USP7_MATH_1 | 273 | 277 | PF00917 | 0.416 |
DOC_USP7_MATH_1 | 36 | 40 | PF00917 | 0.420 |
DOC_USP7_UBL2_3 | 218 | 222 | PF12436 | 0.231 |
LIG_14-3-3_CanoR_1 | 145 | 155 | PF00244 | 0.529 |
LIG_Actin_WH2_2 | 104 | 121 | PF00022 | 0.401 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.573 |
LIG_BIR_III_4 | 138 | 142 | PF00653 | 0.507 |
LIG_BRCT_BRCA1_1 | 240 | 244 | PF00533 | 0.388 |
LIG_eIF4E_1 | 98 | 104 | PF01652 | 0.357 |
LIG_FHA_1 | 2 | 8 | PF00498 | 0.480 |
LIG_FHA_2 | 24 | 30 | PF00498 | 0.427 |
LIG_FHA_2 | 255 | 261 | PF00498 | 0.341 |
LIG_HP1_1 | 264 | 268 | PF01393 | 0.255 |
LIG_LIR_Gen_1 | 188 | 198 | PF02991 | 0.231 |
LIG_LIR_Gen_1 | 46 | 55 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 188 | 194 | PF02991 | 0.231 |
LIG_LIR_Nem_3 | 46 | 51 | PF02991 | 0.432 |
LIG_Pex14_2 | 228 | 232 | PF04695 | 0.388 |
LIG_REV1ctd_RIR_1 | 42 | 51 | PF16727 | 0.303 |
LIG_SH2_CRK | 245 | 249 | PF00017 | 0.304 |
LIG_SH2_CRK | 48 | 52 | PF00017 | 0.323 |
LIG_SH2_CRK | 63 | 67 | PF00017 | 0.311 |
LIG_SH2_NCK_1 | 245 | 249 | PF00017 | 0.388 |
LIG_SH2_STAT5 | 166 | 169 | PF00017 | 0.385 |
LIG_SH2_STAT5 | 265 | 268 | PF00017 | 0.231 |
LIG_SH2_STAT5 | 48 | 51 | PF00017 | 0.366 |
LIG_SH2_STAT5 | 98 | 101 | PF00017 | 0.342 |
LIG_TRAF2_1 | 81 | 84 | PF00917 | 0.450 |
LIG_TYR_ITIM | 61 | 66 | PF00017 | 0.274 |
MOD_CK1_1 | 183 | 189 | PF00069 | 0.527 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.480 |
MOD_CK1_1 | 65 | 71 | PF00069 | 0.433 |
MOD_CK2_1 | 254 | 260 | PF00069 | 0.231 |
MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.499 |
MOD_GlcNHglycan | 124 | 128 | PF01048 | 0.506 |
MOD_GlcNHglycan | 138 | 142 | PF01048 | 0.676 |
MOD_GlcNHglycan | 18 | 21 | PF01048 | 0.500 |
MOD_GSK3_1 | 185 | 192 | PF00069 | 0.383 |
MOD_GSK3_1 | 46 | 53 | PF00069 | 0.385 |
MOD_N-GLC_1 | 36 | 41 | PF02516 | 0.408 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.646 |
MOD_NEK2_1 | 117 | 122 | PF00069 | 0.601 |
MOD_NEK2_1 | 123 | 128 | PF00069 | 0.518 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.362 |
MOD_NEK2_1 | 62 | 67 | PF00069 | 0.403 |
MOD_NEK2_2 | 146 | 151 | PF00069 | 0.561 |
MOD_PKA_1 | 180 | 186 | PF00069 | 0.600 |
MOD_PKA_2 | 146 | 152 | PF00069 | 0.547 |
MOD_PKA_2 | 180 | 186 | PF00069 | 0.600 |
MOD_PKB_1 | 178 | 186 | PF00069 | 0.468 |
MOD_Plk_1 | 162 | 168 | PF00069 | 0.414 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.371 |
MOD_SUMO_rev_2 | 106 | 111 | PF00179 | 0.392 |
MOD_SUMO_rev_2 | 39 | 44 | PF00179 | 0.384 |
TRG_DiLeu_BaEn_1 | 107 | 112 | PF01217 | 0.388 |
TRG_DiLeu_BaEn_4 | 83 | 89 | PF01217 | 0.353 |
TRG_DiLeu_BaLyEn_6 | 113 | 118 | PF01217 | 0.415 |
TRG_ENDOCYTIC_2 | 101 | 104 | PF00928 | 0.384 |
TRG_ENDOCYTIC_2 | 245 | 248 | PF00928 | 0.318 |
TRG_ENDOCYTIC_2 | 265 | 268 | PF00928 | 0.207 |
TRG_ENDOCYTIC_2 | 48 | 51 | PF00928 | 0.366 |
TRG_ENDOCYTIC_2 | 63 | 66 | PF00928 | 0.388 |
TRG_ER_diArg_1 | 144 | 147 | PF00400 | 0.542 |
TRG_ER_diArg_1 | 177 | 180 | PF00400 | 0.369 |
TRG_ER_diArg_1 | 66 | 69 | PF00400 | 0.424 |
TRG_Pf-PMV_PEXEL_1 | 270 | 274 | PF00026 | 0.311 |
TRG_Pf-PMV_PEXEL_1 | 71 | 75 | PF00026 | 0.323 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I6B9 | Leptomonas seymouri | 50% | 100% |
A0A3S7WSF7 | Leishmania donovani | 67% | 100% |
A4HVJ0 | Leishmania infantum | 67% | 100% |
E9AP85 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 66% | 100% |
Q4QG93 | Leishmania major | 70% | 99% |